BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31614335)

  • 1. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
    Onishi S; Kataoka K
    J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATF2 interacts with beta-cell-enriched transcription factors, MafA, Pdx1, and beta2, and activates insulin gene transcription.
    Han SI; Yasuda K; Kataoka K
    J Biol Chem; 2011 Mar; 286(12):10449-56. PubMed ID: 21278380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and regulation of transcription factor MafA in islet beta-cells.
    Aramata S; Han SI; Kataoka K
    Endocr J; 2007 Dec; 54(5):659-66. PubMed ID: 17785922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MafA stability in pancreatic beta cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3.
    Han SI; Aramata S; Yasuda K; Kataoka K
    Mol Cell Biol; 2007 Oct; 27(19):6593-605. PubMed ID: 17682063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Inhibitor of Activated STAT Y (PIASy) Regulates Insulin Secretion by Interacting with LIM Homeodomain Transcription Factor Isl1.
    Yan C; Yu C; Zhang D; Cui Y; Zhou J; Cui S
    Sci Rep; 2016 Dec; 6():39308. PubMed ID: 28000708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1.
    Aramata S; Han SI; Yasuda K; Kataoka K
    Biochim Biophys Acta; 2005 Jul; 1730(1):41-6. PubMed ID: 15993959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene.
    Kataoka K; Han SI; Shioda S; Hirai M; Nishizawa M; Handa H
    J Biol Chem; 2002 Dec; 277(51):49903-10. PubMed ID: 12368292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic beta-cells.
    Ye DZ; Tai MH; Linning KD; Szabo C; Olson LK
    Diabetes; 2006 Mar; 55(3):742-50. PubMed ID: 16505238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity.
    Wang J; Sun Z; Zhang Z; Saadi I; Wang J; Li X; Gao S; Engle JJ; Kuburas A; Fu X; Yu W; Klein WH; Russo AF; Amendt BA
    J Biol Chem; 2013 May; 288(18):12580-95. PubMed ID: 23515314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Krüppel-like protein Gli-similar 3 (Glis3) functions as a key regulator of insulin transcription.
    ZeRuth GT; Takeda Y; Jetten AM
    Mol Endocrinol; 2013 Oct; 27(10):1692-705. PubMed ID: 23927931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMOylation negatively regulates transcriptional and oncogenic activities of MafA.
    Kanai K; Reza HM; Kamitani A; Hamazaki Y; Han SI; Yasuda K; Kataoka K
    Genes Cells; 2010 Sep; 15(9):971-82. PubMed ID: 20718938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contribution of PDX-1, MafA and E47/beta2 to the regulation of the human insulin promoter.
    Docherty HM; Hay CW; Ferguson LA; Barrow J; Durward E; Docherty K
    Biochem J; 2005 Aug; 389(Pt 3):813-20. PubMed ID: 15862113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding.
    Hsieh HT; Wang CH; Wu ML; Yang FM; Tai YC; Hu MC
    Biochem J; 2009 Apr; 419(1):201-9. PubMed ID: 19067654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin remodeling: demethylating H3K4me3 of type I IFNs gene by Rbp2 through interacting with Piasy for transcriptional attenuation.
    Yu X; Chen H; Zuo C; Jin X; Yin Y; Wang H; Jin M; Ozato K; Xu S
    FASEB J; 2018 Feb; 32(2):552-567. PubMed ID: 28970247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIASy represses CCAAT/enhancer-binding protein delta (C/EBPdelta) transcriptional activity by sequestering C/EBPdelta to the nuclear periphery.
    Zhou S; Si J; Liu T; DeWille JW
    J Biol Chem; 2008 Jul; 283(29):20137-48. PubMed ID: 18477566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse MafA, homologue of zebrafish somite Maf 1, contributes to the specific transcriptional activity through the insulin promoter.
    Kajihara M; Sone H; Amemiya M; Katoh Y; Isogai M; Shimano H; Yamada N; Takahashi S
    Biochem Biophys Res Commun; 2003 Dec; 312(3):831-42. PubMed ID: 14680841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration.
    Zhu Y; Liu Q; Zhou Z; Ikeda Y
    Stem Cell Res Ther; 2017 Nov; 8(1):240. PubMed ID: 29096722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.
    Martin N; Schwamborn K; Urlaub H; Gan B; Guan JL; Dejean A
    Mol Cell Biol; 2008 Apr; 28(8):2771-81. PubMed ID: 18285457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
    Gross M; Yang R; Top I; Gasper C; Shuai K
    Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.